# Alfacalcidol Supplementation on Levator Ani Muscle Strength of Menopausal Pelvic Organ Prolapse Patients

> **NCT05505253** · PHASE3 · COMPLETED · sponsor: **Universitas Padjadjaran** · enrollment: 48 (actual)

## Conditions studied

- Pelvic Organ Prolapse

## Interventions

- **DRUG:** Alfacalcidol 0.0005 MG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05505253
- **Lead sponsor:** Universitas Padjadjaran
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-01
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05505253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05505253, "Alfacalcidol Supplementation on Levator Ani Muscle Strength of Menopausal Pelvic Organ Prolapse Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05505253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*